Digoxin immune Fab (ovine) - DIGIFAB intravenous antidote
- Product / population
- DIGIFAB for life-threatening or potentially life-threatening digoxin toxicity; this renal-monitoring record is not an antidote dose calculator.
- Renal measure
- Qualitative severe renal failure; no inferred CrCl bands
Preserve early potassium surveillance and prolonged recurrence monitoring; distinguish free from total digoxin.
Selected named sections only; not a complete monograph or independent clinical approval.
Selected exact-product labeling sections read. Original-source bytes and complete revision histories were not retained or reconciled; retrieval does not establish current product availability.
Renal dosing, restrictions and evidence limits
In severe renal failure, observe for recurrent digitalis toxicity over a prolonged period; free/unbound digoxin may be useful. Total-digoxin assays can remain misleading for days or at least a week when kidney function is markedly impaired. A post-treatment total rise largely reflects Fab-bound digoxin, not active unbound exposure. Obtain a pretreatment sample when possible and monitor ECG, blood pressure and potassium. Follow potassium closely, especially during the first several hours, because reversal can produce rapid hypokalemia. The selected label does not specify a fixed renal observation duration or replacement dose.
Source: https://digifab.health/getmedia/20260204/87131120_20251_NO_V1_DigiFab%20Package%20Insert.pdf